Impaired CTLA-4 responses in COPD are associated with systemic inflammation.
作者信息
Tan Dino B A, Fernandez Sonia, Price Patricia, French Martyn A, Thompson Philip J, Moodley Yuben P
机构信息
1] Centre for Asthma, Allergy and Respiratory Research, Lung Institute of Western Australia, Nedlands, Australia [2] School of Medicine and Pharmacology, Nedlands, Australia.
School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, Australia.
出版信息
Cell Mol Immunol. 2014 Nov;11(6):606-8. doi: 10.1038/cmi.2014.20. Epub 2014 Mar 24.
Abstract
摘要
相似文献
1
Impaired CTLA-4 responses in COPD are associated with systemic inflammation.
Cell Mol Immunol. 2014 Nov;11(6):606-8. doi: 10.1038/cmi.2014.20. Epub 2014 Mar 24.
2
Increased CTLA-4 T cells may contribute to impaired T helper type 1 immune responses in patients with chronic obstructive pulmonary disease.
Immunology. 2017 Jun;151(2):219-226. doi: 10.1111/imm.12725. Epub 2017 Mar 20.
3
Generation and Immune Regulation of CD4CD25Foxp3 T Cells in Chronic Obstructive Pulmonary Disease.
Front Immunol. 2019 Feb 20;10:220. doi: 10.3389/fimmu.2019.00220. eCollection 2019.
4
Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Gastroenterology. 2011 Oct;141(4):1422-31, 1431.e1-6. doi: 10.1053/j.gastro.2011.07.004. Epub 2011 Jul 18.
5
Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Respir Med. 2006 Jun;100(6):1088-93. doi: 10.1016/j.rmed.2005.09.025. Epub 2005 Oct 24.
6
Regulation of IL-17 in chronic inflammation in the human lung.
Clin Sci (Lond). 2011 Jun;120(12):515-24. doi: 10.1042/CS20100417.
7
Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation.
J Immunol. 2013 Aug 15;191(4):1648-56. doi: 10.4049/jimmunol.1300282. Epub 2013 Jul 12.
8
Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Autoimmun Rev. 2012 Jul;11(9):670-7. doi: 10.1016/j.autrev.2011.11.018. Epub 2011 Dec 2.
9
The transcription factor Zfp281 sustains CD4 T lymphocyte activation through directly repressing Ctla-4 transcription.
Cell Mol Immunol. 2020 Dec;17(12):1222-1232. doi: 10.1038/s41423-019-0289-y. Epub 2019 Sep 11.
10
Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice.
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1141-51. doi: 10.1161/ATVBAHA.115.306848. Epub 2016 Apr 7.
引用本文的文献
1
Association of SARS-CoV-2 and Polypharmacy with Gut-Lung Axis: From Pathogenesis to Treatment.
ACS Omega. 2022 Sep 16;7(38):33651-33665. doi: 10.1021/acsomega.2c02524. eCollection 2022 Sep 27.
2
Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection.
Cells. 2022 Jun 7;11(12):1864. doi: 10.3390/cells11121864.
3
Fibrinogen is a promising biomarker for chronic obstructive pulmonary disease: evidence from a meta-analysis.
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20193542.
4
Role of microbiota on lung homeostasis and diseases.
Sci China Life Sci. 2017 Dec;60(12):1407-1415. doi: 10.1007/s11427-017-9151-1. Epub 2017 Oct 9.
5
Levels of CMV-reactive antibodies correlate with the induction of CD28(null) T cells and systemic inflammation in chronic obstructive pulmonary disease (COPD).
Cell Mol Immunol. 2016 Jul;13(4):551-3. doi: 10.1038/cmi.2015.4. Epub 2015 Jan 26.
本文引用的文献
1
The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients.
Int Immunopharmacol. 2011 Nov;11(11):1780-8. doi: 10.1016/j.intimp.2011.06.010. Epub 2011 Jul 23.
2
CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease.
Hum Immunol. 2010 Nov;71(11):1141-6. doi: 10.1016/j.humimm.2010.08.007. Epub 2010 Aug 21.
3
Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence.
Thorax. 2010 Oct;65(10):930-6. doi: 10.1136/thx.2009.130260. Epub 2010 Jul 13.
4
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.
Clin Exp Immunol. 2009 Aug;157(2):316-24. doi: 10.1111/j.1365-2249.2009.03965.x.
5
Immunologic aspects of chronic obstructive pulmonary disease.
N Engl J Med. 2009 Jun 4;360(23):2445-54. doi: 10.1056/NEJMra0804752.
6
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
J Transl Med. 2009 May 20;7:35. doi: 10.1186/1479-5876-7-35.
7
CTLA4 gene polymorphisms are associated with chronic bronchitis.
Eur Respir J. 2009 Sep;34(3):598-604. doi: 10.1183/09031936.00141808. Epub 2009 Apr 22.
8
Influence of smoking cessation on airway T lymphocyte subsets in COPD.
COPD. 2009 Apr;6(2):112-20. doi: 10.1080/15412550902755358.
9
Global burden of COPD: risk factors, prevalence, and future trends.
Lancet. 2007 Sep 1;370(9589):765-73. doi: 10.1016/S0140-6736(07)61380-4.
10
Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
Am J Respir Crit Care Med. 2002 Nov 1;166(9):1218-24. doi: 10.1164/rccm.2202023.
Zotero 插件